PUBLICATIONS OF THE PROBIO TEAM
PROBIO IN THE NEWS
Liquid Biopsy-Based Androgen Receptor Alterations Associated With Advanced Prostate Cancer Outcomes
ABSTRACTS AND ORAL PRESENTATIONS AT SYMPOSIA
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer (See paper)
Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer (See paper)
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis (See paper)
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer (See paper)
Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-Resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns (See paper)
The In Vitro Stability of Circulating Tumour DNA (See paper)
